Tiffany Yating Hsu, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genes, myc | 2 | 2015 | 408 | 0.610 |
Why?
|
| Spliceosomes | 1 | 2015 | 110 | 0.550 |
Why?
|
| Rheumatic Diseases | 4 | 2020 | 526 | 0.520 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2015 | 1004 | 0.250 |
Why?
|
| Antirheumatic Agents | 2 | 2020 | 1347 | 0.200 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2020 | 179 | 0.180 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 26 | 0.150 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 882 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2015 | 3006 | 0.140 |
Why?
|
| RNA Precursors | 1 | 2015 | 216 | 0.130 |
Why?
|
| Breast Neoplasms | 3 | 2015 | 19800 | 0.120 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 385 | 0.120 |
Why?
|
| Introns | 1 | 2015 | 1015 | 0.120 |
Why?
|
| Glutarates | 1 | 2013 | 230 | 0.110 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2011 | 71 | 0.110 |
Why?
|
| Biological Products | 1 | 2020 | 825 | 0.110 |
Why?
|
| Mice, Nude | 2 | 2015 | 3859 | 0.100 |
Why?
|
| RNA Splicing | 1 | 2015 | 877 | 0.100 |
Why?
|
| Cell Dedifferentiation | 1 | 2011 | 138 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2015 | 8638 | 0.100 |
Why?
|
| Isoxazoles | 1 | 2011 | 215 | 0.090 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 2421 | 0.090 |
Why?
|
| HeLa Cells | 1 | 2015 | 3258 | 0.090 |
Why?
|
| Neoplasm Metastasis | 2 | 2015 | 5112 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 3714 | 0.080 |
Why?
|
| Thiophenes | 1 | 2011 | 597 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2015 | 2550 | 0.070 |
Why?
|
| Cell Survival | 1 | 2015 | 6156 | 0.070 |
Why?
|
| Neurogenesis | 1 | 2011 | 833 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2015 | 16959 | 0.060 |
Why?
|
| Astrocytes | 1 | 2011 | 1229 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2014 | 3075 | 0.060 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3153 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3275 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2014 | 7965 | 0.050 |
Why?
|
| Hospitalization | 1 | 2020 | 9644 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 5982 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2015 | 13314 | 0.050 |
Why?
|
| Glioma | 1 | 2011 | 3292 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 1887 | 0.040 |
Why?
|
| Mice | 4 | 2015 | 80876 | 0.030 |
Why?
|
| China | 1 | 2020 | 2251 | 0.030 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2013 | 177 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 3645 | 0.030 |
Why?
|
| Viral Load | 1 | 2020 | 3231 | 0.030 |
Why?
|
| Sumoylation | 1 | 2011 | 86 | 0.030 |
Why?
|
| Glutamine | 1 | 2013 | 567 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2014 | 23950 | 0.030 |
Why?
|
| Animals | 4 | 2015 | 170486 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2014 | 1087 | 0.020 |
Why?
|
| Humans | 9 | 2020 | 708843 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1728 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 542 | 0.020 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2013 | 827 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 2165 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 990 | 0.020 |
Why?
|
| Massachusetts | 1 | 2020 | 8712 | 0.020 |
Why?
|
| Metabolome | 1 | 2013 | 859 | 0.020 |
Why?
|
| Female | 5 | 2020 | 375205 | 0.020 |
Why?
|
| Mitosis | 1 | 2011 | 1250 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2011 | 803 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 2144 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 2427 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2011 | 3014 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8720 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 3507 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 1 | 2011 | 1392 | 0.010 |
Why?
|
| RNA Interference | 1 | 2011 | 3026 | 0.010 |
Why?
|
| Incidence | 1 | 2020 | 20320 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 4677 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 7089 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2013 | 10507 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 2895 | 0.010 |
Why?
|
| Mitochondria | 1 | 2013 | 3665 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2013 | 4099 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2011 | 3464 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 39292 | 0.010 |
Why?
|
| Apoptosis | 1 | 2013 | 10085 | 0.010 |
Why?
|
| Middle Aged | 2 | 2020 | 213752 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9556 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10803 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2011 | 20170 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 69553 | 0.010 |
Why?
|
| Prognosis | 1 | 2013 | 28919 | 0.010 |
Why?
|
| Male | 2 | 2020 | 349524 | 0.010 |
Why?
|
| Neurons | 1 | 2011 | 9385 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 61932 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 161488 | 0.010 |
Why?
|